235 related articles for article (PubMed ID: 12881412)
21. Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells.
Jadhav U; Chigurupati S; Lakka SS; Mohanam S
Int J Oncol; 2004 Nov; 25(5):1407-14. PubMed ID: 15492832
[TBL] [Abstract][Full Text] [Related]
22. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.
Huang CS; Fan YE; Lin CY; Hu ML
J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
D'Alessio S; Fibbi G; Cinelli M; Guiducci S; Del Rosso A; Margheri F; Serratì S; Pucci M; Kahaleh B; Fan P; Annunziato F; Cosmi L; Liotta F; Matucci-Cerinic M; Del Rosso M
Arthritis Rheum; 2004 Oct; 50(10):3275-85. PubMed ID: 15476218
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase-2 (MMP-2) expression and regulation by tumor necrosis factor alpha (TNFalpha) in the bovine corpus luteum.
Zhang B; Yan L; Tsang PC; Moses MA
Mol Reprod Dev; 2005 Feb; 70(2):122-32. PubMed ID: 15570615
[TBL] [Abstract][Full Text] [Related]
25. Membrane type 1-matrix metalloproteinase induces endothelial cell morphogenic differentiation by a caspase-dependent mechanism.
Langlois S; Di Tomasso G; Boivin D; Roghi C; Murphy G; Gingras D; Béliveau R
Exp Cell Res; 2005 Jul; 307(2):452-64. PubMed ID: 15882863
[TBL] [Abstract][Full Text] [Related]
26. Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice.
Nyalendo C; Beaulieu E; Sartelet H; Michaud M; Fontaine N; Gingras D; Béliveau R
Carcinogenesis; 2008 Aug; 29(8):1655-64. PubMed ID: 18621744
[TBL] [Abstract][Full Text] [Related]
27. Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes.
Di Simone N; Di Nicuolo F; Sanguinetti M; Castellani R; D'Asta M; Caforio L; Caruso A
J Endocrinol; 2006 Jun; 189(3):691-9. PubMed ID: 16731799
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
Montero I; Orbe J; Varo N; Beloqui O; Monreal JI; Rodríguez JA; Díez J; Libby P; Páramo JA
J Am Coll Cardiol; 2006 Apr; 47(7):1369-78. PubMed ID: 16580524
[TBL] [Abstract][Full Text] [Related]
29. Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseases.
Naschberger E; Bauer M; Stürzl M
Adv Enzyme Regul; 2005; 45():215-27. PubMed ID: 16005050
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain.
Carter CC; Gorbacheva VY; Vestal DJ
Arch Virol; 2005 Jun; 150(6):1213-20. PubMed ID: 15717119
[TBL] [Abstract][Full Text] [Related]
31. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
32. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
Kim HS; Luo L; Pflugfelder SC; Li DQ
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539
[TBL] [Abstract][Full Text] [Related]
33. Guanylate-binding protein 1 expression from embryonal endothelial progenitor cells reduces blood vessel density and cellular apoptosis in an axially vascularised tissue-engineered construct.
Bleiziffer O; Hammon M; Arkudas A; Taeger CD; Beier JP; Amann K; Naschberger E; Stürzl M; Horch RE; Kneser U
BMC Biotechnol; 2012 Dec; 12():94. PubMed ID: 23217187
[TBL] [Abstract][Full Text] [Related]
34. GBP-1 acts as a tumor suppressor in colorectal cancer cells.
Britzen-Laurent N; Lipnik K; Ocker M; Naschberger E; Schellerer VS; Croner RS; Vieth M; Waldner M; Steinberg P; Hohenadl C; Stürzl M
Carcinogenesis; 2013 Jan; 34(1):153-62. PubMed ID: 23042300
[TBL] [Abstract][Full Text] [Related]
35. Processing and secretion of guanylate binding protein-1 depend on inflammatory caspase activity.
Naschberger E; Geißdörfer W; Bogdan C; Tripal P; Kremmer E; Stürzl M; Britzen-Laurent N
J Cell Mol Med; 2017 Sep; 21(9):1954-1966. PubMed ID: 28272793
[TBL] [Abstract][Full Text] [Related]
36. IFN-γ-response mediator GBP-1 represses human cell proliferation by inhibiting the Hippo signaling transcription factor TEAD.
Unterer B; Wiesmann V; Gunasekaran M; Sticht H; Tenkerian C; Behrens J; Leone M; Engel FB; Britzen-Laurent N; Naschberger E; Wittenberg T; Stürzl M
Biochem J; 2018 Sep; 475(18):2955-2967. PubMed ID: 30120107
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases.
Britzen-Laurent N; Herrmann C; Naschberger E; Croner RS; Stürzl M
World J Gastroenterol; 2016 Jul; 22(28):6434-43. PubMed ID: 27605879
[TBL] [Abstract][Full Text] [Related]
38. GBP-5 splicing variants: New guanylate-binding proteins with tumor-associated expression and antigenicity.
Fellenberg F; Hartmann TB; Dummer R; Usener D; Schadendorf D; Eichmüller S
J Invest Dermatol; 2004 Jun; 122(6):1510-7. PubMed ID: 15175044
[TBL] [Abstract][Full Text] [Related]
39. Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases.
Hammon M; Herrmann M; Bleiziffer O; Pryymachuk G; Andreoli L; Munoz LE; Amann KU; Mondini M; Gariglio M; Airó P; Schellerer VS; Hatzopoulos AK; Horch RE; Kneser U; Stürzl M; Naschberger E
J Cell Mol Med; 2011 Jul; 15(7):1582-92. PubMed ID: 20716116
[TBL] [Abstract][Full Text] [Related]
40. Gamma interferon-induced guanylate binding protein 1 is a novel actin cytoskeleton remodeling factor.
Ostler N; Britzen-Laurent N; Liebl A; Naschberger E; Lochnit G; Ostler M; Forster F; Kunzelmann P; Ince S; Supper V; Praefcke GJ; Schubert DW; Stockinger H; Herrmann C; Stürzl M
Mol Cell Biol; 2014 Jan; 34(2):196-209. PubMed ID: 24190970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
